The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Kish, S. J.
* Articles by Hornykiewicz, O.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Kish, S. J.
* Articles by Hornykiewicz, O.

Am J Psychiatry 1990; 147:1358-1363
Copyright © 1990 by American Psychiatric Association


REGULAR ARTICLES

Brain neurotransmitter changes in three patients who had a fatal hyperthermia syndrome

SJ Kish, R Kleinert, M Minauf, J Gilbert, GF Walter, C Slimovitch, E Maurer, Y Rezvani, R Myers and O Hornykiewicz
Clarke Institute of Psychiatry, University of Toronto, Ont., Canada.

The authors examined the autopsied brains from three patients who had a fatal hyperthermia syndrome. There was marked hypothalamic noradrenaline depletion in all three patients, severe brain choline acetyltransferase deficiency with nucleus basalis cell loss in two patients, and mild to moderate brain choline acetyltransferase loss in one patient. Striatal dopamine metabolite/dopamine ratio was below normal in two patients and not elevated, as would be expected after short-term neuroleptic administration, in the third. This suggests that reduced capability (aggravated by the cholinergic deficit) of the nigrostriatal dopamine system to respond adequately to stress and/or neuroleptic-induced receptor blockade may be important in the development and course of fatal hyperthermia syndrome.


This article has been cited by other articles:


Home page
Journal of Pharmacy PracticeHome page
S. R. White
Acute Dystonic Reaction and the Neuroleptic Malignant Syndrome
Journal of Pharmacy Practice, June 1, 2005; 18(3): 175 - 187.
[Abstract] [PDF]


Home page
Am. J. PsychiatryHome page
R. J. Gurrera
Sympathoadrenal Hyperactivity and the Etiology of Neuroleptic Malignant Syndrome
Am J Psychiatry, February 1, 1999; 156(2): 169 - 180.
[Abstract] [Full Text]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M. KONAGAYA, Y. GOTO, Y. MATSUOKA, T. KONISHI, and Y. KONAGAYA
Neuroleptic malignant syndrome-like condition in multiple system atrophy
J. Neurol. Neurosurg. Psychiatry, July 1, 1997; 63(1): 120a - 121a.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 1990 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org